POINT-GUARD Embolic Protection Device

· Transverse Medical, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for POINT-GUARD Embolic Protection Device, covering 2025-05-08 to 2025-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN) [NA]